Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harari

Showing results (51-60 of 305) with videos related to

Pageof 31
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2010
Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patientsT Czarnowicki, M Harari, T Ruzicka, et al.
Current Oncology Reports|April 2, 2008
EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Paul M Harari
Cancer Treatment and Research|February 2, 2008
Clinical application of EGFR inhibitors in head and neck squamous cell cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
International Journal of Radiation Oncology, Biology, Physics|April 10, 2010
Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancerPaul M Harari, Shiyu Song, Wolfgang A Tomé
Nature Clinical Practice. Oncology|March 1, 2007
Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directionsSøren M Bentzen, Paul M Harari, Jacques Bernier
Current Cancer Drug Targets|December 16, 2006
EGFR-targeting monoclonal antibodies in head and neck cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Seminars in Radiation Oncology|December 28, 2005
Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and RasPrakash Chinnaiyan, Gregory W Allen, Paul M Harari
Molecular Cancer Therapeutics|December 14, 2002
Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockadeShyh-Min Huang, Jing Li, Paul M Harari
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapyS M Huang, J Li, P M Harari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Treating Advanced Head and Neck Cancer When Cisplatin Is Not an OptionSachin R Jhawar, Marcelo Bonomi, Paul M Harari
Pageof 31

Showing results (51-60 of 305) with videos related to

Sort By:
Pageof 31
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2010
Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patientsT Czarnowicki, M Harari, T Ruzicka, et al.
Current Oncology Reports|April 2, 2008
EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neckRanee Mehra, Roger B Cohen, Paul M Harari
Cancer Treatment and Research|February 2, 2008
Clinical application of EGFR inhibitors in head and neck squamous cell cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
International Journal of Radiation Oncology, Biology, Physics|April 10, 2010
Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancerPaul M Harari, Shiyu Song, Wolfgang A Tomé
Nature Clinical Practice. Oncology|March 1, 2007
Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directionsSøren M Bentzen, Paul M Harari, Jacques Bernier
Current Cancer Drug Targets|December 16, 2006
EGFR-targeting monoclonal antibodies in head and neck cancerIgor Astsaturov, Roger B Cohen, Paul M Harari
Seminars in Radiation Oncology|December 28, 2005
Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and RasPrakash Chinnaiyan, Gregory W Allen, Paul M Harari
Molecular Cancer Therapeutics|December 14, 2002
Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockadeShyh-Min Huang, Jing Li, Paul M Harari
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapyS M Huang, J Li, P M Harari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Treating Advanced Head and Neck Cancer When Cisplatin Is Not an OptionSachin R Jhawar, Marcelo Bonomi, Paul M Harari
Pageof 31